These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17015938)

  • 1. Connexin 32 as an anti-invasive and anti-metastatic gene in renal cell carcinoma.
    Yano T; Fujimoto E; Hagiwara H; Sato H; Yamasaki H; Negishi E; Ueno K
    Biol Pharm Bull; 2006 Oct; 29(10):1991-4. PubMed ID: 17015938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of renal cell carcinoma cell proliferation, invasion and metastasis by connexin 32 gene.
    Sato H; Hagiwara H; Ohde Y; Senba H; Virgona N; Yano T
    J Membr Biol; 2007 Mar; 216(1):17-21. PubMed ID: 17565422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma.
    Sato H; Hagiwara H; Senba H; Fukumoto K; Nagashima Y; Yamasaki H; Ueno K; Yano T
    Mol Carcinog; 2008 Jun; 47(6):403-9. PubMed ID: 18058801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
    Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line.
    Fujimoto E; Sato H; Shirai S; Nagashima Y; Fukumoto K; Hagiwara H; Negishi E; Ueno K; Omori Y; Yamasaki H; Hagiwara K; Yano T
    Oncogene; 2005 May; 24(22):3684-90. PubMed ID: 15782139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effect of the Her-2/Her-1 inhibitor PKI-166 on renal cancer cells expressing the connexin 32 gene.
    Fujimoto E; Yano T; Sato H; Hagiwara K; Yamasaki H; Shirai S; Fukumoto K; Hagiwara H; Negishi E; Ueno K
    J Pharmacol Sci; 2005 Feb; 97(2):294-8. PubMed ID: 15699574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic changes of intercellular communication genes during multistage carcinogenesis.
    Yamasaki H; Omori Y; Zaidan-Dagli ML; Mironov N; Mesnil M; Krutovskikh V
    Cancer Detect Prev; 1999; 23(4):273-9. PubMed ID: 10403898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connexin 32 and its derived homotypic gap junctional intercellular communication inhibit the migration and invasion of transfected HeLa cells via enhancement of intercellular adhesion.
    Yang J; Liu B; Wang Q; Yuan D; Hong X; Yang Y; Tao L
    Mol Med Rep; 2011; 4(5):971-9. PubMed ID: 21687945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intercellular communication and carcinogenesis.
    Yamasaki H; Mesnil M; Omori Y; Mironov N; Krutovskikh V
    Mutat Res; 1995 Dec; 333(1-2):181-8. PubMed ID: 8538626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of the CpG island of connexin 32, a candiate tumor suppressor gene in renal cell carcinomas from hemodialysis patients.
    Yano T; Ito F; Kobayashi K; Yonezawa Y; Suzuki K; Asano R; Hagiwara K; Nakazawa H; Toma H; Yamasaki H
    Cancer Lett; 2004 May; 208(2):137-42. PubMed ID: 15142671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
    Hagiwara H; Sato H; Shirai S; Kobayashi S; Fukumoto K; Ishida T; Seki T; Ariga T; Yano T
    Life Sci; 2006 Apr; 78(19):2249-54. PubMed ID: 16289236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.
    Fujimoto E; Sato H; Nagashima Y; Negishi E; Shirai S; Fukumoto K; Hagiwara H; Hagiwara K; Ueno K; Yano T
    Life Sci; 2005 Apr; 76(23):2711-20. PubMed ID: 15792837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between connexins, gap junctions, tissue architecture and tumour invasion, as studied in a novel in vitro model of HPV-16-associated cervical cancer progression.
    Aasen T; Hodgins MB; Edward M; Graham SV
    Oncogene; 2003 Sep; 22(39):7969-80. PubMed ID: 12970745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative growth control of HeLa cells by connexin genes: connexin species specificity.
    Mesnil M; Krutovskikh V; Piccoli C; Elfgang C; Traub O; Willecke K; Yamasaki H
    Cancer Res; 1995 Feb; 55(3):629-39. PubMed ID: 7834634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-suppressive effect of connexin 32 in renal cell carcinoma from maintenance hemodialysis patients.
    Yano T; Ito F; Satoh H; Hagiwara K; Nakazawa H; Toma H; Yamasaki H
    Kidney Int; 2003 Jan; 63(1):381. PubMed ID: 12472808
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of gap junctions in tumor suppression: analysis of genetically-manipulated mice.
    Omori Y; Zaidan Dagli ML; Yamakage K; Yamasaki H
    Mutat Res; 2001 Jun; 477(1-2):191-6. PubMed ID: 11376700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Connexin32 as a tumor suppressor gene in renal cell carcinoma].
    Fujimoto E; Yano T; Ueno K
    Nihon Yakurigaku Zasshi; 2007 Feb; 129(2):105-9. PubMed ID: 17299236
    [No Abstract]   [Full Text] [Related]  

  • 18. Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2.
    Fujimoto E; Satoh H; Negishi E; Ueno K; Nagashima Y; Hagiwara K; Yamasaki H; Yano T
    Mol Carcinog; 2004 Jul; 40(3):135-42. PubMed ID: 15224345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32.
    Krutovskikh V; Mazzoleni G; Mironov N; Omori Y; Aguelon AM; Mesnil M; Berger F; Partensky C; Yamasaki H
    Int J Cancer; 1994 Jan; 56(1):87-94. PubMed ID: 8262683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging roles of gap junction proteins connexins in cancer metastasis, chemoresistance and clinical application.
    Wu JI; Wang LH
    J Biomed Sci; 2019 Jan; 26(1):8. PubMed ID: 30642339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.